Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
UBS
Chubb
Queensland Health
Federal Trade Commission
US Army
Mallinckrodt
Cipla
Cerilliant

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018677

« Back to Dashboard

NDA 018677 describes CESAMET, which is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. Additional details are available on the CESAMET profile page.

The generic ingredient in CESAMET is nabilone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nabilone profile page.
Summary for 018677
Tradename:CESAMET
Applicant:Mylan Speciality Lp
Ingredient:nabilone
Patents:0
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details
Pharmacology for NDA: 018677
Ingredient-typeCannabinoids
Suppliers and Packaging for NDA: 018677
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CESAMET nabilone CAPSULE;ORAL 018677 NDA Meda Pharmaceuticals Inc. 0037-1221 N 0037-1221-50

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength1MG
Approval Date:Dec 26, 1985TE:RLD:Yes

Expired US Patents for NDA 018677

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp CESAMET nabilone CAPSULE;ORAL 018677-001 Dec 26, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Baxter
Julphar
QuintilesIMS
Chinese Patent Office
Cerilliant
Federal Trade Commission
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.